| UniProt ID | NFYC_HUMAN | |
|---|---|---|
| UniProt AC | Q13952 | |
| Protein Name | Nuclear transcription factor Y subunit gamma | |
| Gene Name | NFYC | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 458 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Component of the sequence-specific heterotrimeric transcription factor (NF-Y) which specifically recognizes a 5'-CCAAT-3' box motif found in the promoters of its target genes. NF-Y can function as both an activator and a repressor, depending on its interacting cofactors.. | |
| Protein Sequence | MSTEGGFGGTSSSDAQQSLQSFWPRVMEEIRNLTVKDFRVQELPLARIKKIMKLDEDVKMISAEAPVLFAKAAQIFITELTLRAWIHTEDNKRRTLQRNDIAMAITKFDQFDFLIDIVPRDELKPPKRQEEVRQSVTPAEPVQYYFTLAQQPTAVQVQGQQQGQQTTSSTTTIQPGQIIIAQPQQGQTTPVTMQVGEGQQVQIVQAQPQGQAQQAQSGTGQTMQVMQQIITNTGEIQQIPVQLNAGQLQYIRLAQPVSGTQVVQGQIQTLATNAQQGQRNASQGKPRRCLKETLQITQTEVQQGQQQFSQFTDGQRNSVQQARVSELTGEAEPREVKATGNSTPCTSSLPTTHPPSHRAGASCVCCSQPQQSSTSPPPSDALQWVVVEVSGTPNQLETHRELHAPLPGMTSLSPLHPSQQLYQIQQVTMPAGQDLAQPMFIQSANQPSDGQAPQVTGD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 (in isoform 5) | Phosphorylation | - | 34.86 | 24719451 | |
| 2 | Phosphorylation | ------MSTEGGFGG ------CCCCCCCCC | 34.86 | 24719451 | |
| 3 | Phosphorylation | -----MSTEGGFGGT -----CCCCCCCCCC | 37.03 | 28464451 | |
| 10 | Phosphorylation | TEGGFGGTSSSDAQQ CCCCCCCCCCHHHHH | 26.30 | 28348404 | |
| 11 | Phosphorylation | EGGFGGTSSSDAQQS CCCCCCCCCHHHHHH | 30.99 | 28348404 | |
| 12 | Phosphorylation | GGFGGTSSSDAQQSL CCCCCCCCHHHHHHH | 31.88 | 28348404 | |
| 13 | Phosphorylation | GFGGTSSSDAQQSLQ CCCCCCCHHHHHHHH | 36.41 | 28464451 | |
| 36 | Ubiquitination | EIRNLTVKDFRVQEL HHHCCCCCCCCCCCC | 46.01 | 21890473 | |
| 36 | Ubiquitination | EIRNLTVKDFRVQEL HHHCCCCCCCCCCCC | 46.01 | 23000965 | |
| 36 | Ubiquitination | EIRNLTVKDFRVQEL HHHCCCCCCCCCCCC | 46.01 | 21890473 | |
| 36 (in isoform 3) | Ubiquitination | - | 46.01 | 21890473 | |
| 36 (in isoform 2) | Ubiquitination | - | 46.01 | 21890473 | |
| 36 (in isoform 1) | Ubiquitination | - | 46.01 | 21890473 | |
| 36 | Ubiquitination | EIRNLTVKDFRVQEL HHHCCCCCCCCCCCC | 46.01 | 21890473 | |
| 36 | Ubiquitination | EIRNLTVKDFRVQEL HHHCCCCCCCCCCCC | 46.01 | 21890473 | |
| 53 | Ubiquitination | ARIKKIMKLDEDVKM HHHHHHHCCCCCHHC | 57.15 | - | |
| 56 | Ubiquitination | KKIMKLDEDVKMISA HHHHCCCCCHHCCCC | 75.13 | 23000965 | |
| 59 (in isoform 1) | Ubiquitination | - | 42.72 | 21890473 | |
| 59 (in isoform 2) | Ubiquitination | - | 42.72 | 21890473 | |
| 59 (in isoform 3) | Ubiquitination | - | 42.72 | 21890473 | |
| 59 | Ubiquitination | MKLDEDVKMISAEAP HCCCCCHHCCCCCHH | 42.72 | 21963094 | |
| 79 | Ubiquitination | AAQIFITELTLRAWI HHHHHHHHHHHEEEE | 34.63 | 21963094 | |
| 92 | 2-Hydroxyisobutyrylation | WIHTEDNKRRTLQRN EEECCCCCCCEECHH | 56.42 | - | |
| 92 | Ubiquitination | WIHTEDNKRRTLQRN EEECCCCCCCEECHH | 56.42 | - | |
| 103 | Sulfoxidation | LQRNDIAMAITKFDQ ECHHHHHHHHHEHHH | 2.57 | 21406390 | |
| 106 | Phosphorylation | NDIAMAITKFDQFDF HHHHHHHHEHHHCCE | 19.00 | 23663014 | |
| 124 | Ubiquitination | IVPRDELKPPKRQEE ECCHHHCCCCCCHHH | 58.17 | - | |
| 127 | Ubiquitination | RDELKPPKRQEEVRQ HHHCCCCCCHHHHHH | 75.21 | - | |
| 258 | O-linked_Glycosylation | IRLAQPVSGTQVVQG EEEECCCCCCEEEEH | 42.69 | 30059200 | |
| 260 | O-linked_Glycosylation | LAQPVSGTQVVQGQI EECCCCCCEEEEHHH | 15.64 | 30059200 | |
| 282 | Phosphorylation | QQGQRNASQGKPRRC HHHHHHHHCCCCCHH | 42.91 | 22985185 | |
| 285 | Ubiquitination | QRNASQGKPRRCLKE HHHHHCCCCCHHHHH | 27.93 | - | |
| 325 | Phosphorylation | SVQQARVSELTGEAE HHHHHHHHHHHCCCC | 22.72 | 28555341 | |
| 339 | Phosphorylation | EPREVKATGNSTPCT CCCEEECCCCCCCCC | 31.04 | 23312004 | |
| 339 | O-linked_Glycosylation | EPREVKATGNSTPCT CCCEEECCCCCCCCC | 31.04 | 30059200 | |
| 342 | Phosphorylation | EVKATGNSTPCTSSL EEECCCCCCCCCCCC | 34.76 | 25159151 | |
| 343 | Phosphorylation | VKATGNSTPCTSSLP EECCCCCCCCCCCCC | 26.78 | 25159151 | |
| 343 | O-linked_Glycosylation | VKATGNSTPCTSSLP EECCCCCCCCCCCCC | 26.78 | 30059200 | |
| 346 | Phosphorylation | TGNSTPCTSSLPTTH CCCCCCCCCCCCCCC | 23.66 | 23312004 | |
| 346 | O-linked_Glycosylation | TGNSTPCTSSLPTTH CCCCCCCCCCCCCCC | 23.66 | 30059200 | |
| 347 | Phosphorylation | GNSTPCTSSLPTTHP CCCCCCCCCCCCCCC | 36.27 | 23312004 | |
| 348 | Phosphorylation | NSTPCTSSLPTTHPP CCCCCCCCCCCCCCC | 21.88 | 23312004 | |
| 351 | Phosphorylation | PCTSSLPTTHPPSHR CCCCCCCCCCCCCCC | 42.92 | 23312004 | |
| 352 | Phosphorylation | CTSSLPTTHPPSHRA CCCCCCCCCCCCCCC | 30.37 | 23312004 | |
| 356 | Phosphorylation | LPTTHPPSHRAGASC CCCCCCCCCCCCCEE | 30.01 | 28555341 | |
| 373 | Phosphorylation | CSQPQQSSTSPPPSD ECCCCCCCCCCCCCC | 28.68 | 22210691 | |
| 375 | Phosphorylation | QPQQSSTSPPPSDAL CCCCCCCCCCCCCCC | 37.04 | 22210691 | |
| 410 | Phosphorylation | HAPLPGMTSLSPLHP CCCCCCCCCCCCCCH | 32.22 | 26074081 | |
| 411 | Phosphorylation | APLPGMTSLSPLHPS CCCCCCCCCCCCCHH | 20.25 | 26074081 | |
| 413 | Phosphorylation | LPGMTSLSPLHPSQQ CCCCCCCCCCCHHHH | 25.78 | 26074081 | |
| 418 | Phosphorylation | SLSPLHPSQQLYQIQ CCCCCCHHHHHEEEE | 21.58 | 26074081 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NFYC_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NFYC_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NFYC_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...